Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patient demographics

From: Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction

Demographic Subset Value
general total number 18
male 15
  female 3
age (years) mean 65
  median 63
histology adenocarcinoma 18
  other 18
stage T3N0 1
T3N1 14
T3N2 2
  other 0